M3, Inc. Stock OTC Markets

Equities

MTHRY

US55379N1063

Internet Services

Delayed OTC Markets 01:36:00 2024-07-11 pm EDT 5-day change 1st Jan Change
4.812 USD +1.53% Intraday chart for M3, Inc. +3.49% -41.38%
Sales 2025 * 267B 1.68B Sales 2026 * 294B 1.85B Capitalization 1,061B 6.68B
Net income 2025 * 47.65B 300M Net income 2026 * 54.32B 342M EV / Sales 2025 * 3.41 x
Net cash position 2025 * 152B 960M Net cash position 2026 * 169B 1.06B EV / Sales 2026 * 3.04 x
P/E ratio 2025 *
22.3 x
P/E ratio 2026 *
19.5 x
Employees 12,100
Yield 2025 *
1.45%
Yield 2026 *
1.54%
Free-Float 60.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.53%
1 week+3.49%
Current month+0.89%
1 month-0.36%
3 months-24.57%
6 months-41.31%
Current year-41.38%
More quotes
1 week
4.52
Extreme 4.52
4.87
1 month
4.52
Extreme 4.52
4.90
Current year
4.52
Extreme 4.52
8.78
1 year
4.52
Extreme 4.52
11.90
3 years
4.52
Extreme 4.52
41.49
5 years
4.52
Extreme 4.52
52.42
10 years
4.52
Extreme 4.52
52.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 00-09-28
Director/Board Member 52 09-12-31
Director/Board Member 51 -
Members of the board TitleAgeSince
Chief Executive Officer 59 00-09-28
Director/Board Member 66 14-05-31
Director/Board Member 64 00-09-28
More insiders
Date Price Change Volume
24-07-11 4.812 +1.53% 83 819
24-07-10 4.74 +0.42% 302,393
24-07-09 4.72 +1.51% 189,910
24-07-08 4.65 0.00% 107,809
24-07-05 4.65 +0.43% 113,490

Delayed Quote OTC Markets, July 11, 2024 at 01:36 pm EDT

More quotes
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows: - medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE; - support services to medical institutions (16.5%): - clinical trial related services (10.7%): clinical trial support and clinical trial operations management services; - human resources services (6.6%); - other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites. The balance of sales (24.3%) concerns international activities.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,520 JPY
Average target price
2,215 JPY
Spread / Average Target
+45.75%
Consensus